EC Emergency Medicine and Critical Care

Case Report Volume 6 Issue 8 - 2022

Hemorrhagic Stroke on Vitamin K Antagonist

Larbi Aberouch*, Salim Chajai, Youssef Garda, Ali Kettani and Mamoun Faroudy

Resuscitation and Surgical Emergency Unit, Ibn Sina Hospital, Rabat, Morocco

*Corresponding Author: Larbi Aberouch, Resuscitation and Surgical Emergency Unit, Ibn Sina Hospital, Rabat, Morocco.
Received: July 28, 2022; Published: July 29, 2022



Hemorrhagic stroke may be subdivided into intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Intracerebral hematomas represent 10% of serious haemorrhages under VKA. We report a case of a 43 years old patient, who had an intracranial hemorrhage one month after a heart surgery.

Literature say that the cerebral CT scan and Brain MRI make the diagnosis of intracerebral hematoma with very good sensitivity and specificity. The prognosis imposes an optimization of the treatments to act on the main determinants of the prognosis: the growth of the hematoma, to prevent secondary brain injury of systemic origin, to treat the systemic consequences of cerebral suffering, to prevent re-bleeding in the context of SAH, to identify and treat patients undergoing urgent surgery or radio-interventional procedures.

Keywords: Hemorrhagic Stroke; Intracerebral Hemorrhage (ICH); Subarachnoid Hemorrhage (SAH)

  1. Unnithan AKA., et al. “Hemorrhagic Stroke”. Treasure Island (FL): StatPearls Publishing (2022).
  2. Ojaghihaghighi S., et al. “Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke”. World Journal of Emergency Medicine 1 (2017): 34-38.
  3. Chimowitz MI., et al. “Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis”. The New England Journal of Medicine 13 (2005): 1305-1316.
  4. Anderson CS., et al. “Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial”. Lancet Neurology 5 (2008): 391-399.
  5. Rosand J., et al. “The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage”. Archives of Internal Medicine 8 (2004): 880-884.
  6. The Kothari RU., et al. “ABCs of measuring intracerebral hemorrhage volumes”. Stroke8 (1996): 1304-1305.
  7. Kidwell CS., et al. “Comparison of MRI and CT for detection of acute intracerebral hemorrhage”. The Journal of the American Medical Association 15 (2004): 1823-1830.
  8. Fiebach JB., et al. “Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging”. Stroke2 (2004): 502-506.
  9. Y L’hermitte., et al. “Hemmoragic stroke”. Urgences (2013).
  10. Vigué B., et al. “Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage”. Intensive Care Medicine 4 (2007): 721-725.
  11. Mendelow AD., et al. “Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas - International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial”. Lancet9457 (2005): 387-397.

Larbi Aberouch., et al. Hemorrhagic Stroke on Vitamin K Antagonist. EC Emergency Medicine and Critical Care  6.8 (2022): 20-24.